Next Article in Journal
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections
Next Article in Special Issue
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis
Previous Article in Journal
Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
Previous Article in Special Issue
Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis
 
 
Article

Article Versions Notes

Vaccines 2022, 10(5), 694; https://doi.org/10.3390/vaccines10050694
Action Date Notes Link
article xml file uploaded 28 April 2022 15:23 CEST Original file -
article xml uploaded. 28 April 2022 15:23 CEST Update -
article pdf uploaded. 28 April 2022 15:23 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/694/pdf-vor
article html file updated 28 April 2022 15:24 CEST Original file -
article xml file uploaded 4 May 2022 14:47 CEST Update -
article xml uploaded. 4 May 2022 14:47 CEST Update https://www.mdpi.com/2076-393X/10/5/694/xml
article pdf uploaded. 4 May 2022 14:47 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/694/pdf
article html file updated 4 May 2022 14:49 CEST Update -
article html file updated 2 August 2022 21:21 CEST Update https://www.mdpi.com/2076-393X/10/5/694/html
Back to TopTop